A shared inflammatory signature across severe malaria syndromes manifested by transcriptomic, proteomic and metabolomic analyses

R Rafal S. Sobota E Emily M. Stucke D Drissa Coulibaly J Jonathan G. Lawton B Bryan E. Cummings S Savy Sebastian A Antoine Dara J James B. Munro (Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School) A Amed Ouattara A Abdoulaye K. Kone B Bourama Kane K Karim Traore B Bouréima Guindo B Bourama M. Tangara A Amadou Niangaly N Noah T. Ventimiglia M Modibo Daou I Issa Diarra Y Youssouf Tolo M Mody Sissoko F Fayçal Maiga A Aichatou Diawara A Amidou Traore A Ali Thera M Matthew B. Laurens K Kirsten E. Lyke B Bourèma Kouriba O Ogobara K. Doumbo C Christopher V. Plowe D David R. Goodlett J Joana C. Silva M Mahamadou A. Thera M Mark A. Travassos

Abstract

Abstract Factors governing the clinical trajectory of Plasmodium falciparum infection remain an important area of investigation. Here we present transcriptomic, proteomic and metabolomic analyses comparing clinical subtypes of severe Plasmodium falciparum malaria to matched controls with uncomplicated disease in 79 children from Mali. MMP8, IL1R2, and ARG1 transcription is higher across cerebral malaria, severe malarial anemia, and concurrent cerebral malaria and severe malarial anemia, indicating a shared inflammatory signature. Tissue inhibitor of metalloproteinases 1 is the most upregulated protein in cerebral malaria, which along with elevated MMP8 and MMP9 transcription, underscores the importance of the metalloproteinase pathway in central nervous system pathophysiology. L-arginine metabolites are decreased in cerebral malaria, which coupled with increased ARG1 transcription suggests a putative mechanism impairing cerebral vasodilation. Using multi-omics approaches, we thus describe the inflammatory cascade in severe malaria syndromes, and identify potential therapeutic targets and biological markers.

Article Details

Volume / Issue Vol. 16, Issue 1
Published May 18, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (33)

R

Rafal S. Sobota

E

Emily M. Stucke

D

Drissa Coulibaly

J

Jonathan G. Lawton

B

Bryan E. Cummings

S

Savy Sebastian

A

Antoine Dara

J

James B. Munro

Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School

A

Amed Ouattara

A

Abdoulaye K. Kone

B

Bourama Kane

K

Karim Traore

B

Bouréima Guindo

B

Bourama M. Tangara

A

Amadou Niangaly

N

Noah T. Ventimiglia

M

Modibo Daou

I

Issa Diarra

Y

Youssouf Tolo

M

Mody Sissoko

F

Fayçal Maiga

A

Aichatou Diawara

A

Amidou Traore

A

Ali Thera

M

Matthew B. Laurens

K

Kirsten E. Lyke

B

Bourèma Kouriba

O

Ogobara K. Doumbo

C

Christopher V. Plowe

D

David R. Goodlett

J

Joana C. Silva

M

Mahamadou A. Thera

M

Mark A. Travassos